# Indaptus Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Jun 26, 2026

- Company: [Indaptus Therapeutics, Inc.](/companies/indp.md) (CIK 1857044)
- Form: SCHEDULE 13D/A
- Filed: 2026-06-26
- Accepted by EDGAR: Jun 26, 2026, 21:40 ET
- Period: not reported
- Accession: 0001829126-26-006953
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1857044/000182912626006953/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1857044/000182912626006953/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1857044/000182912626006953/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Jun 26, 2026.
Source: SEC EDGAR, the filing index for accession 0001829126-26-006953. Last ingested by Listed: Nov 14, 2026, 21:10 ET. No prices; not investment advice.
